source
- Dr Jones on the Protective Benefit and Tolerability of GLP-1 Agonists vs Aspirin for CRC PreventionColton Jones, MD, shares data from a retrospective analysis of GLP-1 receptor agonists vs aspirin for the primary prevention of colorectal cancer.onclive · 3mo ago↗ source
- IO in NMIBC, Radioligand Therapy in mHSPC Highlight Key Presentations to Watch at AUA 2026Ahead of the 2026 AUA Annual Meeting, GU cancer experts highlighted the abstracts that they are anticipating the most.onclive · 3mo ago↗ source
- Ibrutinib Monotherapy Yields Decade-Long Durable Efficacy in Across CLL SubtypesIbrutinib monotherapy produced durable efficacy over 10 years in patients with or without TP53-mutated chronic lymphocytic leukemia.